These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 30320385

  • 1. Long non‑coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer.
    Xue Z, Zhu X, Teng Y.
    Mol Med Rep; 2018 Dec; 18(6):5173-5181. PubMed ID: 30320385
    [Abstract] [Full Text] [Related]

  • 2. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S, Liu S, Feng J, Gao J, Xue F.
    Cancer Biomark; 2019 Dec; 24(4):421-428. PubMed ID: 30909184
    [Abstract] [Full Text] [Related]

  • 3. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
    Zhou T, Zhong M, Zhang S, Wang Z, Xie R, Xiong C, Lv Y, Chen W, Yu J.
    Cancer Biomark; 2018 Dec; 23(2):185-191. PubMed ID: 30175973
    [Abstract] [Full Text] [Related]

  • 4. Silencing the long noncoding RNA, TINCR, a molecular sponge of miR‑335, inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression.
    Li R, Wang Y, Xu Y, He X, Li Y.
    Int J Oncol; 2019 Nov; 55(5):1110-1124. PubMed ID: 31545411
    [Abstract] [Full Text] [Related]

  • 5. E2F1-regulated long non-coding RNA RAD51-AS1 promotes cell cycle progression, inhibits apoptosis and predicts poor prognosis in epithelial ovarian cancer.
    Zhang X, Liu G, Qiu J, Zhang N, Ding J, Hua K.
    Sci Rep; 2017 Jun 30; 7(1):4469. PubMed ID: 28667302
    [Abstract] [Full Text] [Related]

  • 6. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
    Qiu JJ, Lin XJ, Tang XY, Zheng TT, Zhang XY, Hua KQ.
    Int J Cancer; 2020 May 01; 146(9):2588-2598. PubMed ID: 31577838
    [Abstract] [Full Text] [Related]

  • 7. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
    Ma SY, Wei P, Qu F.
    Eur Rev Med Pharmacol Sci; 2019 Jun 01; 23(11):4629-4641. PubMed ID: 31210304
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
    Zhuang XH, Liu Y, Li JL.
    Biosci Rep; 2019 Aug 30; 39(8):. PubMed ID: 31337688
    [Abstract] [Full Text] [Related]

  • 9. The long noncoding RNA cancer susceptibility candidate 2 inhibits tumor progression in osteosarcoma.
    Lu L, Dai Z, Luo Q, Lv G.
    Mol Med Rep; 2018 Jan 30; 17(1):1947-1953. PubMed ID: 29257211
    [Abstract] [Full Text] [Related]

  • 10. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
    Long X, Song K, Hu H, Tian Q, Wang W, Dong Q, Yin X, Di W.
    J Exp Clin Cancer Res; 2019 Aug 07; 38(1):345. PubMed ID: 31391118
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of lncRNA CASC2 by microRNA-21 increases the proliferation and migration of renal cell carcinoma cells.
    Cao Y, Xu R, Xu X, Zhou Y, Cui L, He X.
    Mol Med Rep; 2016 Jul 07; 14(1):1019-25. PubMed ID: 27222255
    [Abstract] [Full Text] [Related]

  • 12. LncRNA SNHG20 predicts a poor prognosis and promotes cell progression in epithelial ovarian cancer.
    Wang D, Dai J, Hou S, Qian Y.
    Biosci Rep; 2019 Apr 30; 39(4):. PubMed ID: 30846486
    [Abstract] [Full Text] [Related]

  • 13. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
    Zhao J, Liu HR.
    Eur Rev Med Pharmacol Sci; 2019 Apr 30; 23(8):3243-3252. PubMed ID: 31081076
    [Abstract] [Full Text] [Related]

  • 14. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA, Todeschini P, Siegel ER, Calza S, Cappella P, Ardighieri L, Cadei M, Bugatti M, Romani C, Bandiera E, Zanotti L, Tassone L, Guarino D, Santonocito C, Capoluongo ED, Beltrame L, Erba E, Marchini S, D'Incalci M, Donzelli C, Santin AD, Pecorelli S, Sartori E, Bignotti E, Odicino F, Ravaggi A.
    J Exp Clin Cancer Res; 2017 May 08; 36(1):63. PubMed ID: 28482906
    [Abstract] [Full Text] [Related]

  • 15. E2F6-mediated lncRNA CASC2 down-regulation predicts poor prognosis and promotes progression in gastric carcinoma.
    Li Y, Jiang L, Lv S, Xu H, Fan Z, He Y, Wen H.
    Life Sci; 2019 Sep 01; 232():116649. PubMed ID: 31301415
    [Abstract] [Full Text] [Related]

  • 16. Low expression of long noncoding RNA CASC2 indicates a poor prognosis and promotes tumorigenesis in thyroid carcinoma.
    Xiong X, Zhu H, Chen X.
    Biomed Pharmacother; 2017 Sep 01; 93():391-397. PubMed ID: 28654795
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
    Qiu JJ, Lin YY, Ye LC, Ding JX, Feng WW, Jin HY, Zhang Y, Li Q, Hua KQ.
    Gynecol Oncol; 2014 Jul 01; 134(1):121-8. PubMed ID: 24662839
    [Abstract] [Full Text] [Related]

  • 18. Low Expression of LncRNA Cancer Susceptibility Candidate 2 and its Clinical Significance in Cancer Tissues.
    Zhu ZM, Liu FT, Chen X.
    Cell Physiol Biochem; 2018 Jul 01; 46(4):1643-1649. PubMed ID: 29694965
    [Abstract] [Full Text] [Related]

  • 19. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
    Huang F, Zhang Q, Chen W, Zhang H, Lu G, Chen J, Qiu C.
    J Cell Biochem; 2019 Jun 01; 120(6):10380-10390. PubMed ID: 30609134
    [Abstract] [Full Text] [Related]

  • 20. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y, Wang H, Huang Q, Wu J, Zhang M.
    J Ovarian Res; 2022 Jan 15; 15(1):8. PubMed ID: 35031063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.